ANI Pharmaceuticals (ANIP)

[Just the facts maam]

If the cancer drug in question is Lansopazole ODT, Dexcel just received FDA approval on June 7th (TAD?). Seeing that ANI and Dexcel have struck up a partnership on two other drugs, it is possible that they were conducting the bio-study and FDA submissions.


12/11/14 - Przybyl stated that 4 previously approved drugs acquired from Teva required biostudies of which one was for LANSOPRAZOLE ODT for which there is no generic competition to Tekeda $250 million drug (Prevacid). They were working on a new bio-study which should be completed by end of 2015.


Since the drug was under expedited review the timing seems to fit. Especially, since ANI has not mentioned Lansoprazole ODT in quite a while.